Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 6th MENA Congress for Rare Diseases 2027 brings together healthcare professionals to explore advances in the diagnosis, treatment, and multidisciplinary management of rare diseases. The congress will highlight genomic medicine, innovative therapies, pediatric rare diseases, patient-centered care, and strategies to improve access to specialized services across the MENA region.
The 6th MENA Congress for Rare Diseases 2027 provides a comprehensive platform for discussing the evolving landscape of rare disease diagnosis and management. The program will address genetic and genomic medicine, inborn errors of metabolism, rare neurological and hematological disorders, immunological conditions, and complex pediatric diseases. Participants will explore advances in molecular diagnostics, precision medicine, newborn screening, and emerging therapeutic approaches. The congress will also examine innovative treatments such as gene therapy, enzyme replacement, and targeted therapies that are transforming rare disease care. Multidisciplinary approaches will be emphasized to support coordinated management and improve long-term outcomes for patients and families. Sessions will also highlight research, clinical trials, patient registries, healthcare access, and regional collaboration. Through expert presentations and knowledge exchange, participants will gain practical insights into improving rare disease care across the MENA region.
Latest advancements and novel therapeutic approaches for treating rare diseases.
Modern diagnostic tools and updates in identifying rare genetic and systemic conditions.
Exploration of cell and gene therapies as potential cures for rare genetic disorders.
The role of artificial intelligence in accelerating diagnosis and research in rare diseases.
Focus on rare bone, eye, immune, blood, lung, and heart diseases.
In-depth sessions on Angelman syndrome, Duchenne muscular dystrophy, and Huntington disease.
Specialized dental care and nutritional interventions for patients with rare diseases.
Addressing the psychological, social, and rehabilitative needs of patients and their families.
Understanding the intersection of rare diseases with neurodivergence and autism spectrum disorders.
Navigating the economic impact and insurance coverage challenges associated with rare diseases.
The role of media and patient advocacy groups in raising awareness and driving policy changes.
Promoting inclusion and diversity in rare disease research, education, and community support.
Examination of new treatment modalities and their potential to transform outcomes for patients with rare diseases.
Strategies for integrating multiple specialties to provide comprehensive, patient-centered care.
Importance of data collection and regional collaboration in improving research, diagnosis, treatment, and disease understanding.
The congress offers up to 21 expected CME credits for participating healthcare professionals.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow